Granulocyte colony stimulating factor use during anticancer therapy

Summary. With the aim of increasing the effectiveness of anticancer therapy more aggressive radio- and chemotherapy is developing ang using. However, intensification of primary treatment leads to the development of severe complications, which in turn, head off the implementation of treatment in optimal regimens. This factors are reducing efficiency of therapy and worsen the quality of patient’s life. The introduction of the recombinant forms of granulocyte colony-stimulating factors has allowed to solve a lot of problems in the treatment and prevention of neutropenia and its complications in patients suffering from neoplastic diseases.